Atlas Trials

Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

RecordFirmDate
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy (NCT01728480)Roswell Park Cancer Institute2014-01-01
Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy (NCT01674374)Roswell Park Cancer Institute2013-05-01
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer (NCT01528137)Stanford University2012-05-01
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck (NCT01334177)University of Washington2011-06-01
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy (NCT01682031)Roswell Park Cancer Institute2009-06-01
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT00906360)National Cancer Institute (NCI)2008-07-01
Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00513435)National Cancer Institute (NCI)2007-07-01
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089)National Cancer Institute (NCI)2007-06-01
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348)National Cancer Institute (NCI)2005-01-01
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00089362)National Cancer Institute (NCI)2004-07-01
Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck (NCT00081211)National Cancer Institute (NCI)2004-04-01
Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer (NCT00055770)National Cancer Institute (NCI)2002-10-01
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00023959)National Cancer Institute (NCI)2001-07-01

Track Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity automatically

Every clearance here is in the API, with alerts when new ones post.